HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles.

AbstractAIM:
We examined whether HLA-DRB1*1501 and four VDR SNPs influence the macrophage response to infection with Mycobacterium tuberculosis (Mtb) via innate immune versus drug treatment or drug delivery mechanisms.
MATERIALS & METHODS:
Monocyte-derived macrophages from 24 healthy donors were infected with Mtb in vitro. Survival of intracellular bacilli and secretion of cytokines and nitric oxide by the infected cells were monitored with and without exposure to isoniazid and rifabutin.
RESULTS:
Haplotype analysis was conducted, and an arbitrary score of genetic 'susceptibility' (S ) score ranging from -3 to +3 was assigned to donors based on the presence or absence of genetic markers. S scores correlated more strongly with Mtb survival (r = 0.68) than TNF and nitric oxide (NO; r = ∼0.01-0.11). A specific haplotype was significantly associated with decreased Mtb survival (p < 0.05), increased NO and decreased IL-10/IL-4. Macrophages with S scores ≥ 2 secreted significantly (p < 0.05) more IL-10 and IL-4, and less NO upon infection, and supported Mtb survival. Microparticulate drugs showed higher bactericidal activity than free drugs, irrespective of S score.
CONCLUSION:
S score predicts colonization of macrophages by Mtb, as does haplotype analysis. Drug-containing microparticles are superior to free drugs across diverse genetic backgrounds.
AuthorsAmit K Singh, Abhimanyu, Awadh B Yadav, Sandeep Sharma, Rajiv Garg, Mridula Bose, Amit Misra
JournalPharmacogenomics (Pharmacogenomics) Vol. 14 Issue 5 Pg. 531-40 (Apr 2013) ISSN: 1744-8042 [Electronic] England
PMID23556450 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-DRB1 Chains
  • Receptors, Calcitriol
  • VDR protein, human
  • Rifabutin
  • Nitric Oxide
  • Isoniazid
Topics
  • Cell Survival (drug effects)
  • Drug Delivery Systems
  • HLA-DRB1 Chains (genetics)
  • Haplotypes
  • Humans
  • Immunity, Innate (drug effects)
  • Isoniazid (administration & dosage)
  • Macrophages (drug effects, microbiology, pathology)
  • Mycobacterium tuberculosis (drug effects, genetics, pathogenicity)
  • Nitric Oxide (metabolism)
  • Polymorphism, Single Nucleotide
  • Receptors, Calcitriol (genetics)
  • Rifabutin (administration & dosage)
  • Tuberculosis (drug therapy, genetics, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: